Bausch Health
315 hedge funds and large institutions have $3.65B invested in Bausch Health in 2017 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 78 increasing their positions, 94 reducing their positions, and 53 closing their positions.
55% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 53
47% more capital invested
Capital invested by funds: $2.48B → $3.65B (+$1.16B)
9% more funds holding
Funds holding: 289 → 315 (+26)
0.24% more ownership
Funds ownership: 49.98% → 50.21% (+0.24%)
17% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 94
34% less call options, than puts
Call options by funds: $717M | Put options by funds: $1.09B
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$93.1M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$49.5M |
| 3 |
Two Sigma Investments
New York
|
+$43.7M |
| 4 |
Morgan Stanley
New York
|
+$40.2M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$30.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$86.7M |
| 2 |
CAM
Chou Associates Management
Toronto,
Ontario, Canada
|
-$46.1M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$39.1M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$26.8M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$25.5M |
BHC Hedge Fund Activity: Q4 2017 in Review
315 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2017, worth a combined $3.65B — up 47% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new BHC positions and 53 closed out — a net gain of 29 holders — while 78 added to existing stakes and 94 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $93.1M. The largest seller was Susquehanna International Group, cutting an estimated $86.7M.
- 315 institutional investors held Bausch Health (BHC) as of Q4 2017, up from 289 in Q3 2017.
- Funds reported $3.65B of Bausch Health stock for Q4 2017, up 47% quarter-over-quarter.
- 82 funds opened new Bausch Health positions in Q4 2017 and 53 closed out, a net change of +29 holders.
- The largest Bausch Health buyer in Q4 2017 was Renaissance Technologies, an estimated $93.1M added.
- The largest Bausch Health seller in Q4 2017 was Susquehanna International Group, an estimated $86.7M sold.
Based on aggregated 13F filings for Q4 2017.